A disease that affects less than 200,000 people in the United States at any given time is classified as a rare disease. There are over 6,800 rare diseases, according to the National Human Genome Research Institute. Approximately 80% of rare diseases are believed to have a genetic origin.
The stock we are revisiting today is that of Rezolute Inc. (RZLT), a late-stage rare disease company focused on developing transformative therapies for rare diseases with serious unmet needs. Its lead drug candidate is Ersodetug, under development for treating hypoglycemia (low blood sugar levels) due to any congenital or acquired form of Hyperinsulinism, say, Tumour-related HI.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.